AlloVir, Inc. - Common Stock (NQ:ALVR)

9.810 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AlloVir, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Moderna, BioNTech And Other Big Stocks Moving Higher On Monday ↗

August 21, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 150 points on Monday. Here are some big stocks recording gains in today’s session. Genelux Corporation (NASDAQ: GNLX) gained 19.2% to $28.58....

Via Benzinga

Topics Stocks

AlloVir's RSV Therapy Is Underappreciated Gem, BofA Comments On Future Potential ↗

August 18, 2023

B of A Securities analyst Jason Zemansky initiated coverage on AlloVir Inc (NASDAQ: ALVR) with a Buy rating and

Via Benzinga

AlloVir Reports Second Quarter 2023 Financial Results

August 03, 2023

From AlloVir, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 31, 2023

Via Benzinga

Why Shares of AlloVir Plummeted This Week ↗

June 23, 2023

The clinical-stage biotech's shares fell after the company announced a stock sale.

Via The Motley Fool

Why AlloVir Stock Is Diving Thursday ↗

June 22, 2023

AlloVir Inc (NASDAQ: ALVR) shares are trading lower after the company priced a public offering of common stock.

Via Benzinga

Why Is AlloVir (ALVR) Stock Down 23% Today? ↗

June 22, 2023

AlloVir (ALVR) stock is falling hard on Thursday after the company announced the pricing of a $75 million public share offering.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023 ↗

August 18, 2023

Via Benzinga

MarketBeat Week in Review – 7/10 - 7/14

July 15, 2023

As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week

Via MarketBeat

Topics Economy

Why AlloVir Stock Is Tumbling After Hours ↗

June 21, 2023

AlloVir Inc (NASDAQ: ALVR) shares are trading lower in Wednesday's after-hours session after the company proposed a public offering.

Via Benzinga

Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus

July 13, 2023

Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth.

Via MarketBeat

Topics Retirement

BlackBerry, Micron And Other Big Stocks Moving Higher In Thursday's Pre-Market Session ↗

June 29, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. BlackBerry Limited (NYSE: BB) shares climbed 18.5% to $5.94 in pre-market...

Via Benzinga

$11M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying ↗

June 29, 2023

The Dow Jones closed lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...

Via Benzinga

Mercury Systems And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

June 26, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet ↗

June 22, 2023

U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 22, 2023

Via Benzinga

Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher ↗

June 22, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P...

Via Benzinga

Tesla (TSLA) Stock Slides After Second Downgrade This Week ↗

June 22, 2023

Tesla (TSLA) stock is on the move Thursday after the company got hit with its second downgrade this week, despite increased price targets.

Via InvestorPlace

US Stocks Lower Following Initial Jobless Claims Report ↗

June 22, 2023

U.S. stocks traded lower this morning, with Nasdaq Composite dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.16% to 33,895.80 while the NASDAQ fell...

Via Benzinga

Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 22, 2023

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...

Via Benzinga

Why Is Gulfport Energy (GPOR) Stock Down 8% Today? ↗

June 22, 2023

Gulfport Energy (GPOR) stock is falling on Thursday after the company revealed details of a public share offering from certain investors.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 22, 2023

Via Benzinga

Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket ↗

June 22, 2023

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 100.8% to $2.65 in pre-market trading after dropping 43% on Wednesday.

Via Benzinga

AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

June 22, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market...

Via Benzinga

AlloVir Announces Pricing of Public Offering of Common Stock

June 21, 2023

From AlloVir, Inc.

Via Business Wire

AlloVir Announces Proposed Public Offering of Common Stock

June 21, 2023

From AlloVir, Inc.

Via Business Wire

Why Shares of AlloVir Jumped This Week ↗

June 09, 2023

The company's lead therapy fared well in preventing infections for kidney transplant patients.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 06, 2023

Via Benzinga

AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023)

June 05, 2023

From AlloVir, Inc.

Via Business Wire

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.